enteric pathogenic bacteria

基本解釋

AIM : To evaluate the clinical and bacterial effectiveness and safety of levofloxacin (LVLX) made in China in the treatment of enteric pathogenic bacteria.
目的：為觀察國產(chǎn)左氟沙星（LVLX）治療腸道細菌感染的療效、細菌學效果和安全性。
Objective To monitor the distribution and resistance of enteric pathogenic bacteria in Beijing area to offer the data for guiding epidemiologic study and clinical treatment.
目的監(jiān)測北京地區(qū)腸道致病菌的組成及耐藥狀況，為本地區(qū)的流行病學研究及臨床合理用藥提供依據(jù)。
Results The amplicons of Yersinia pestis DNA were the same with the anticipative products. Only internal control amplicon was gotten while amplifying other enteric pathogenic bacteria DNA.
結果鼠疫菌DNA模板可擴增出預期產(chǎn)物，而其他菌株只能擴增出內(nèi)部對照模板的片段。